Form 4 for KMTS KESTRA MEDICAL TECHNOLOGIES, LTD.
Accepted 2025-12-31 00:00:00 ET · period of report 2025-12-29 · accession 0001193125-25-338322 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2025-12-31 | 2025-12-29 | KMTS | Webster Brian Daniel | See Remarks, Dir | S - Sale | $26.59 | -15.0K | 409.8K | -4% | -$398.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-12-29 | S | D | 15,000 | $26.59 | 409,786 | D | — | — | (F2) The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $26.390 to $26.9504. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. (F3) Includes 27,209 Common Shares received from West Affum Holdings, L.P. in a pro rata distribution exempt pursuant to Rule 16a-9. |